Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
M Etminan, F Forooghian, D Maberley - Cmaj, 2012 - Can Med Assoc
Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
[PDF][PDF] Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
M Etminan, F Forooghian… - Canadian Medical …, 2012 - Can Med Assoc
Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
M Etminan, F Forooghian… - Canadian Medical …, 2012 - search.ebscohost.com
Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
M Etminan, F Forooghian… - … journal= journal de l' …, 2012 - pubmed.ncbi.nlm.nih.gov
Background There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
MD Farzin Forooghian… - Canadian Medical …, 2012 - search.proquest.com
Results: The cohort comprised 934 147 people, including 10 827 first-time users of
bisphosphonates and 923 320 nonusers. The incidence rate among first-time users was …
bisphosphonates and 923 320 nonusers. The incidence rate among first-time users was …
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
M Etminan, F Forooghian, D Maberley - CMAJ: Canadian Medical …, 2012 - europepmc.org
Background There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
[HTML][HTML] Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
M Etminan, F Forooghian… - CMAJ: Canadian Medical …, 2012 - ncbi.nlm.nih.gov
Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
[PDF][PDF] Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
CMAJ, 2012 - epe.lac-bac.gc.ca
Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …